On Mar 10, 2022 Freeline closed a Post-IPO Equity round and raised $26,100,000 from Syncona Partners LLP, featuring lead investors Syncona Partners LLP. About the […]
Post-IPO Equity – Puma Biotechnology
On Mar 10, 2022 Puma Biotechnology closed a Post-IPO Equity round and raised $10,000,000 from Alan H. Auerbach, Athyrium Capital Management LP, featuring lead investors […]
Post-IPO Equity – Freeline
On Mar 10, 2022 Freeline closed a Post-IPO Equity round and raised $26,100,000 from Syncona Partners LLP, featuring lead investors Syncona Partners LLP. About the […]
Venture Round – RefleXion Medical
On Mar 10, 2022 RefleXion Medical closed a Venture – Series Unknown round and raised $80,000,000 from Ally Bridge Group, Ascension Ventures, Catalio Capital Management, […]
Post-IPO Equity – Hookipa Pharma
On Mar 2, 2022 Hookipa Pharma closed a Post-IPO Equity round and raised $75,000,000 from investors, featuring lead investors . About the company: Hookipa Pharma […]
Series B – Epsilogen
On Mar 2, 2022 Epsilogen closed a Series B round and raised £30,750,000 from 3B Future Health Fund, ALSA Ventures, British Patient Capital, Caribou Property, […]
Series C – SeLux Diagnostics
On Feb 28, 2022 SeLux Diagnostics closed a Series C round and raised $50,000,000 from Northpond Ventures, RA Capital Management, Sands Capital, Schooner Capital, featuring […]
Series C – SeLux Diagnostics
On Feb 28, 2022 SeLux Diagnostics closed a Series C round and raised $50,000,000 from Northpond Ventures, RA Capital Management, Sands Capital, Schooner Capital, featuring […]
Series A – Engimmune Therapeutics
On Feb 21, 2022 Engimmune Therapeutics closed a Series A round and raised CHF500,000 from BaseLaunch, featuring lead investors BaseLaunch. About the company: Engimmune Therapeutics […]
Venture Round – Locus Biosciences
On Feb 14, 2022 Locus Biosciences closed a Venture – Series Unknown round and raised $10,500,000 from investors, featuring lead investors . About the company: […]
